Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lymphoma 8Lymphoma, Follicular 7Leukemia 7Prostatic Neoplasms 4Leukemia, Lymphocytic, Chronic, B-Cell 4Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Glioblastoma 3Burkitt Lymphoma 3Astrocytoma 3Stomach Neoplasms 2Rectal Neoplasms 2Neoplasms, Plasma Cell 2Neoplasm Metastasis 2Multiple Myeloma 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myeloid, Chronic-Phase 2Colonic Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Brain Neoplasms 2Wilms Tumor 1Urinary Bladder Neoplasms 1

Interventions

ixabepilone 2aldesleukin 2Oxaliplatin 2sargramostim 1rF-B7.1 vaccine 1peginterferon alfa-2b 1indolepropanol phosphate 1fludarabine phosphate 1birinapant 1becatecarin 1alvocidib 1Topotecan 1Sorafenib 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1O(6)-benzylguanine 1Nitroarginine 1Methods 1Magnetic Resonance Spectroscopy 1Lapatinib 1Interleukin-2 1Ifosfamide 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gemcitabine 1Fluorodeoxyglucose F18 1Filgrastim 1Early Intervention, Educational 1Docetaxel 1Decitabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Unspecified Adult Solid Tumor, Protocol Specific × sargramostim × Clear all
NCT00009958 2013-05-16

Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer

National Cancer Institute (NCI)

Phase 1 Terminated
42 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡